EP0147437A4 - Dry direct compression compositions for controlled release dosage forms. - Google Patents

Dry direct compression compositions for controlled release dosage forms.

Info

Publication number
EP0147437A4
EP0147437A4 EP19840902301 EP84902301A EP0147437A4 EP 0147437 A4 EP0147437 A4 EP 0147437A4 EP 19840902301 EP19840902301 EP 19840902301 EP 84902301 A EP84902301 A EP 84902301A EP 0147437 A4 EP0147437 A4 EP 0147437A4
Authority
EP
European Patent Office
Prior art keywords
dosage forms
controlled release
release dosage
direct compression
dry direct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19840902301
Other languages
German (de)
French (fr)
Other versions
EP0147437A1 (en
Inventor
Choong-Gook Jang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0147437A1 publication Critical patent/EP0147437A1/en
Publication of EP0147437A4 publication Critical patent/EP0147437A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP19840902301 1983-05-31 1984-05-29 Dry direct compression compositions for controlled release dosage forms. Withdrawn EP0147437A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US49922183A 1983-05-31 1983-05-31
US499221 1983-05-31
US60047284A 1984-04-16 1984-04-16
US600472 1984-04-16

Publications (2)

Publication Number Publication Date
EP0147437A1 EP0147437A1 (en) 1985-07-10
EP0147437A4 true EP0147437A4 (en) 1987-03-05

Family

ID=27053077

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19840902301 Withdrawn EP0147437A4 (en) 1983-05-31 1984-05-29 Dry direct compression compositions for controlled release dosage forms.

Country Status (5)

Country Link
EP (1) EP0147437A4 (en)
JP (1) JPH0759502B2 (en)
AU (2) AU581177B2 (en)
BR (1) BR8406921A (en)
WO (1) WO1984004674A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524003A1 (en) 1985-07-04 1987-01-08 Heumann Ludwig & Co Gmbh MEDICINE GRANULES WITH DELAYED ACTIVE SUBSTANCE RELEASE AND METHOD FOR THE PRODUCTION THEREOF
SE455836B (en) * 1985-10-11 1988-08-15 Haessle Ab PREPARATION WITH CONTROLLED RELEASE CONTAINING A SALT OF METOPROLOL AND METHOD FOR PREPARING THIS PREPARATION
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
US4983399A (en) * 1989-10-18 1991-01-08 Eastman Kodak Company Direct compression carrier composition
US5385887A (en) * 1993-09-10 1995-01-31 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
US5458888A (en) * 1994-03-02 1995-10-17 Andrx Pharmaceuticals, Inc. Controlled release tablet formulation
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
EP1390383B1 (en) 2001-05-11 2012-02-29 Isis Pharmaceuticals, Inc. Antisense permeation enhancers
US20030012820A1 (en) * 2001-06-12 2003-01-16 Upadhyay Ajay Hasmukhlal Compressible guaifenesin compositions, method for making same and method for making compressed guaifenesin dosage forms therefrom
ES2426445T3 (en) 2006-04-07 2013-10-23 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US8999383B2 (en) 2008-05-07 2015-04-07 Merrion Research Iii Limited Compositions of GnRH related compounds and processes of preparation
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
WO2012094598A2 (en) 2011-01-07 2012-07-12 Merrion Research Iii Limited Pharmaceutical compositions of iron for oral administration
US10722458B2 (en) * 2011-12-02 2020-07-28 Pegasus Laboratories, Inc. Amphipathic lipid-based sustained release compositions
US10265384B2 (en) 2015-01-29 2019-04-23 Novo Nordisk A/S Tablets comprising GLP-1 agonist and enteric coating
US20170114189A1 (en) * 2015-10-27 2017-04-27 Tenstech Inc. Cellulosic microsheets

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3108046A (en) * 1960-11-25 1963-10-22 Smith Kline French Lab Method of preparing high dosage sustained release tablet and product of this method
DE2050701A1 (en) * 1969-10-17 1971-05-06 Shinetsu Chemical Co ,Tokio Auxiliary material for the production of medicaments in the form of easily disintegrating solid bodies

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE564759A (en) * 1955-12-22
US3402240A (en) * 1957-06-25 1968-09-17 Pfizer & Co C Medicinal tablet and process of making same
US3096248A (en) * 1959-04-06 1963-07-02 Rexall Drug & Chemical Company Method of making an encapsulated tablet
US3062720A (en) * 1959-05-20 1962-11-06 Philips Roxane Sustained release pharmaceutical tablet
US3115441A (en) * 1962-06-06 1963-12-24 Victor M Hermelin Timed release pharmaceutical preparations and method of making the same
US3279998A (en) * 1962-06-22 1966-10-18 Smith Kline French Lab Method of preparing sustained release tablets
BE636865A (en) * 1962-08-31
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
US3336200A (en) * 1963-05-28 1967-08-15 Warner Lambert Pharmaceutical Tablet structure
NL297631A (en) * 1963-06-03
US3362880A (en) * 1963-09-20 1968-01-09 Dow Chemical Co Compressed drug tablets of ethyl cellulose, glyceryl monostearate, karaya gum, tragacanth, talc, and magnesium stearate
US3400197A (en) * 1965-01-26 1968-09-03 Robins Co Inc A H Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
FR2183546B1 (en) * 1972-05-10 1975-06-20 Servier Lab
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
AU1873783A (en) * 1982-10-08 1984-04-12 Verex Laboratories Inc. Constant release formulation
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3108046A (en) * 1960-11-25 1963-10-22 Smith Kline French Lab Method of preparing high dosage sustained release tablet and product of this method
DE2050701A1 (en) * 1969-10-17 1971-05-06 Shinetsu Chemical Co ,Tokio Auxiliary material for the production of medicaments in the form of easily disintegrating solid bodies

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO8404674A1 *

Also Published As

Publication number Publication date
JPS60501459A (en) 1985-09-05
BR8406921A (en) 1985-06-04
AU581177B2 (en) 1989-02-16
AU3475189A (en) 1989-09-07
AU2967684A (en) 1984-12-18
JPH0759502B2 (en) 1995-06-28
EP0147437A1 (en) 1985-07-10
WO1984004674A1 (en) 1984-12-06

Similar Documents

Publication Publication Date Title
DE3375283D1 (en) Extended action controlled release compositions
GB8307960D0 (en) Sustained release therapeutic compositions
DE3370937D1 (en) Aqueous fire-extinguishing composition
GB8326436D0 (en) Galenic compositions
EP0147437A4 (en) Dry direct compression compositions for controlled release dosage forms.
ZA834074B (en) Pharmaceutical composition
GB2122490B (en) Controlled release formulation
PH18846A (en) Phthalazine compounds,compositions and use
EP0093551A3 (en) Pharmaceutical composition
DE3368855D1 (en) Fungicidal composition
IL70520A0 (en) Substituted phenyl sulfonyloxybenzimidazole-carbamates,process for their preparation and pharmaceutical compositions containing the same
GB8308990D0 (en) Flame retarder
GB2156216B (en) Compositions for cosmetic, health-and body-preserving use
GB2141023B (en) Delayed release formulations
OA07917A (en) Fumigating composition.
GB2113729B (en) Chloroisocyanurate compositions
GB8329700D0 (en) Anti-haemophilic pharmaceutical composition
GB8328896D0 (en) Pharmaceutical composition
DE3375391D1 (en) Indole compounds, their preparation and pharmaceutical compositions comprising them
GB8319304D0 (en) Release cement
GB8405085D0 (en) Controlled release formulation
GB8400396D0 (en) Endoparasiticidal compositions
ZA848732B (en) Dry direct compression compositions for controlled release dosage forms
DE3366925D1 (en) Physiologically active pterocarpan compounds, methods for the isolation thereof and therapeutically active compositions containing them
GB8332653D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB LI LU NL SE

17P Request for examination filed

Effective date: 19850729

A4 Supplementary search report drawn up and despatched

Effective date: 19870305

17Q First examination report despatched

Effective date: 19880811

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19900609